The 21st century is proving to be one of the most exciting and prolific periods of innovation in biosciences and healthcare. Advances across biology, technology, engineering and data science are converging to help create new, potentially life-changing solutions for individuals and societies across the globe.
BIA has identified areas of strategic importance in this new and exciting age of science. Choose an area to learn more, read case studies and see how R&D is already making an impact on people's lives.
UK biotech companies are at the forefront of these innovative, converging disciplines. These companies are a key part of our membership. As the trade association for innovative life science companies in the UK, we provide a home for these groups through our Advisory Committees, working groups and networks.
Deep Biotech
The BIA has coined a new term ‘Deep Biotech’ to describe the application of modern biotechnologies to humanity's most profound challenges beyond health, including climate change, pollution and food security.
Engineering biology (also called ‘synthetic biology’), is industrialising DNA sequencing, manufacture and editing, making all of it cheaper and more accessible – rather like Microsoft Word did for text-editing.
Biotech companies are using cutting-edge techniques from data-driven tech to transform drug discovery and patient care. We call this interface of biology and technology “techbio".
Genomics, the study of DNA, is transforming healthcare with personalised medicines that target diseases effectively and minimise side effects. It’s also driving precise diagnostics to characterise and prevent diseases. The BIA aims to build on the UK’s strong genomics heritage, working with stakeholders and members to make the UK the best place to scale genomics companies.
mRNA is a molecule that carries instructions from DNA to the ribosomes, where proteins are made. Proteins are the building blocks of life and are responsible for a wide range of functions, including cell structure, metabolism, and signalling.